utrophin Inhibitors

Common utrophin Inhibitors include, but are not limited to PD 98059 CAS 167869-21-8, LY 294002 CAS 154447-36-6, SP600125 CAS 129-56-6, U-0126 CAS 109511-58-2 and Wortmannin CAS 19545-26-7.

Utrophin, often denoted by its gene name UTRN, is a substantial actin-binding protein that bears both structural and functional resemblances to dystrophin. These proteins are integral to the preservation of muscle fiber integrity, operating as connectors between the internal cytoskeleton of muscle cells and the external extracellular matrix. While dystrophin is a predominant presence in muscle fibers throughout the body, utrophin's expression is notably concentrated at the neuromuscular junction in adults. Their primary role revolves around offering mechanical stability, safeguarding muscle fibers from damage during contraction and relaxation phases.

Utrophin inhibitors would be molecules or strategies specifically designed to curtail the expression, activity, or stability of the utrophin protein. Inhibitors might encompass small molecules that hinder the protein's function or antisense oligonucleotides that target utrophin mRNA, thus hindering its translation. Other inhibitory approaches might focus on the post-translational modification and stability of the protein. By inhibiting utrophin, it could be possible to glean deeper insights into its exact role in muscle function and its interactions with other crucial cytoskeletal proteins. A comprehensive understanding of the repercussions of diminished utrophin activity could shed light on muscle biology's intricacies and the elaborate protein network ensuring muscle health and operation.